Communiqués CapForce Inc.

Actions

CFOR

US68373L5057

Technologie financière (Fintech)

Marché Fermé - OTC Markets Autres places de cotation 16:58:04 24/07/2026			Varia. 5j.	Varia. 1 janv.
18,00 ^USD	+131,36%		-10,00%	+13,21%

12/06	CapForce Inc. publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI
26/05	CapForce Inc. publie ses résultats pour l'exercice clos le 31 décembre 2025	CI

Communiqués

27/02	OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.	AQ
24/05/24	OpGen Receives Expected Nasdaq Notice Regarding Delayed Form 10-Q	AQ
16/05/24	OpGen Announced 1-for-10 Reverse Stock Split	AQ
29/04/24	OpGen Provides Update on Business Operations and Strategic Opportunities	AQ
23/04/24	OpGen Receives Nasdaq Notice Regarding Delayed Form 10-K	AQ
17/04/24	OpGen : Management Change/Compensation - Form 8-K	PU
25/03/24	OpGen Announces Acquisition of Preferred Stock by David Lazar	AQ
05/12/23	OpGen : Accelaration/Increase of Financial Obligation - Form 8-K	PU
14/11/23	OpGen Reports Third Quarter 2023 Financial Results and Provides Business Update	AQ
12/10/23	OpGen Enters Into Warrant Inducement Transaction for up to $11.2 Million in Gross Proceeds	AQ
11/08/23	OpGen : Corporate Presentation	PU
10/08/23	OpGen Reports Second Quarter 2023 Financial Results and Provides Business Update	AQ
07/08/23	OpGen’s Subsidiary Ares Genetics Releases New Features to its AREScloud Offering	AQ
03/08/23	OpGen’s Subsidiary Curetis and FIND Extend R&D Collaboration Agreement	AQ
03/08/23	OpGen to Provide Business Update and Financial Results for the Second Quarter 2023 on August 10th at 4:30 p.m. Eastern Time	AQ
19/07/23	OpGen’s Subsidiary Curetis Meets Milestones of Extended and Expanded R&D Collaboration with FIND	AQ
05/07/23	OpGen : Corporate Presentation	PU
26/06/23	OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe	AQ
22/06/23	OpGen’s Subsidiary Curetis Receives Batch of Ten New C-Series Unyvero A30 Instruments	AQ
20/06/23	OpGen Presents Unyvero Urinary Tract Infection Panel Trial Results at ASM Microbe 2023 Conference	AQ
01/06/23	OpGen : Corporate Presentation	PU
15/05/23	OpGen Reports First Quarter 2023 Financial Results and Provides Business Update	AQ
08/05/23	OpGen to Provide Business Update and Financial Results for the First Quarter 2023 on May 15th at 4:30 p.m. Eastern Time	AQ
05/05/23	OpGen : Corporate Presentation	PU
04/05/23	OPGEN INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	AQ